Get Premium to unlock powerful stock data
NAS:AKUS (USA)  
Akouos Inc logo

Akouos Inc

$ 3.46 +0.35 (+11.25%) 10:08 PM EST
P/E:
At Loss
P/B:
0.52
Market Cap:
$ 119.81M
Enterprise V:
$ -72.28M
Volume:
273.54K
Avg Vol (2M):
560.82K
Volume:
273.54K
Market Cap $:
119.81M
PE Ratio:
At Loss
Avg Vol (2-Month):
560.82K
Enterprise Value $:
-72.28M
PB Ratio:
0.52
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Akouos Inc
NAICS : 541714 SIC : 2833
645 Summer Street, Suite 200, Boston, MA, USA, 02210
Description
Akouos Inc is a genetic medicine company focused on developing gene therapies that restore, improve, and preserve hearing. The company is involved in developing potential genetic medicines for a variety of inner ear disorders.
Name Current Vs Industry Vs History
Cash-To-Debt 7.18
Equity-to-Asset 0.82
Debt-to-Equity 0.14
Debt-to-EBITDA -0.31
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -28.3
3-Year EPS without NRI Growth Rate -39.2
3-Year FCF Growth Rate -23.3

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 37.61
9-Day RSI 43.35
14-Day RSI 46.34
6-1 Month Momentum % -61.4
12-1 Month Momentum % -75.44

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 11.39
Quick Ratio 11.39
Cash Ratio 11.27

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -75
Name Current Vs Industry Vs History
ROE % -38.35
ROA % -33.17
ROIC % -95.01
ROC (Joel Greenblatt) % -256.17
ROCE % -34.82

Financials (Next Earnings Date:2022-08-12 Est.)

AKUS's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:AKUS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -2.83
Beta 0
Volatility % 81.41
14-Day RSI 46.34
14-Day ATR ($) 0.770717
20-Day SMA ($) 4.049
12-1 Month Momentum % -75.44
52-Week Range ($) 2.315 - 13.69
Shares Outstanding (Mil) 34.63

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Akouos Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More